Research

Cellular

Metformin failed to prove beneficial effects in MASLD progression.

Avoid using metformin for treating MASLD progression as it has not shown benefits.

StrongRefutesmedium confidence
Metformin failed to prove beneficial effects in MASLD progression.
Marios Zisis et al. · Biomolecules · 2025

Why this rating

Based on the review of metformin's effects.

Source

Linking Cardiovascular Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): The Role of Cardiometabolic Drugs in MASLD Treatment

Marios Zisis et al. · Biomolecules · 2025

DOI 10.3390/biom15030324

reviewCited 30×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →